Section 33 of DCA : Section 33: Power Of Central Government To Make Rules
DCA
JavaScript did not load properly
Some content might be missing or broken. Please try disabling content blockers or use a different browser like Chrome, Safari or Firefox.
Explanation using Example
Imagine a pharmaceutical company, "HealthPlus Pharma," is planning to introduce a new antibiotic drug to the Indian market. Before they can proceed, they need to ensure that their product complies with the regulations set out by the Central Government under the Drugs and Cosmetics Act, 1940. Specifically, they must adhere to the rules formulated under Section 33 of the Act.
As per these rules, HealthPlus Pharma must:
- Have their drug tested and analyzed at an established laboratory to confirm it is of standard quality (as per rule (a))
- Ensure that the drug packaging includes the date of manufacture and the expiry date, and that it is not sold after the expiry date (as per rule (h))
- Comply with the prescribed methods of test or analysis to prove the drug's quality (as per rule (c))
- Adhere to the rules regarding the labelling of the drug, ensuring that it does not claim to prevent or cure diseases or ailments not specified by the regulations (as per rules (j) and (f))
- Apply for the appropriate license for manufacturing and selling the antibiotic, following the conditions provided for such licenses (as per rule (e))
If HealthPlus Pharma fails to comply with any of these rules, they could face the cancellation or suspension of their license as well as other penalties prescribed by the Act.
Update: Our Pro subscription pricing is now simplified. See our Pro plans
Update: Our AI tools are cooking — and they are almost ready to serve! Stay hungry — your invite to the table is coming soon.
Update: KanoonGPT Chat interface is launched for beta testing. Try it out here